The global market for Drug Addiction Therapy was estimated to be worth US$ 700 million in 2023 and is forecast to a readjusted size of US$ 1080.7 million by 2030 with a CAGR of 6.4% during the forecast period 2024-2030

Drug Addiction Therapy - Market

The global drug addiction therapy market is segmented into tobacco/nicotine e-cigarettes, alcohol, cannabis, synthetic cannabinoids, opioids, stimulants, prescription and over-the-counter drugs, and others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Addiction Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Addiction Therapy by region & country, by Type, and by Application.

The Drug Addiction Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Addiction Therapy.

Market Segmentation

Scope of Drug Addiction Therapy - Market Report

Report Metric	Details
Report Name	Drug Addiction Therapy - Market
Forecasted market size in 2030	US$ 1080.7 million
CAGR	6.4%
Forecasted years	2024 - 2030
Segment by Type:	Tobacco Nicotine Vaping
Segment by Application	Hospitals Homecare Drug Rehabilitation Center
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer,Inc., Indivior PLC, Novartis AG, Alkermes, Viatris,Inc., Teva Pharmaceutical Industries,Ltd., Mallinckrodt Pharmaceutical, Hikma Pharmaceuticals PLC, Orexo AB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Addiction Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Addiction Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Addiction Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Drug Addiction Therapy - Market size in 2030?

Ans: The Drug Addiction Therapy - Market size in 2030 will be US$ 1080.7 million.

Who are the main players in the Drug Addiction Therapy - Market report?

Ans: The main players in the Drug Addiction Therapy - Market are Pfizer,Inc., Indivior PLC, Novartis AG, Alkermes, Viatris,Inc., Teva Pharmaceutical Industries,Ltd., Mallinckrodt Pharmaceutical, Hikma Pharmaceuticals PLC, Orexo AB

What are the Application segmentation covered in the Drug Addiction Therapy - Market report?

Ans: The Applications covered in the Drug Addiction Therapy - Market report are Hospitals, Homecare, Drug Rehabilitation Center

What are the Type segmentation covered in the Drug Addiction Therapy - Market report?

Ans: The Types covered in the Drug Addiction Therapy - Market report are Tobacco, Nicotine, Vaping

1 Market Overview

1.1 Drug Addiction Therapy Product Introduction

1.2 Global Drug Addiction Therapy Market Size Forecast

1.3 Drug Addiction Therapy Market Trends & Drivers

1.3.1 Drug Addiction Therapy Industry Trends

1.3.2 Drug Addiction Therapy Market Drivers & Opportunity

1.3.3 Drug Addiction Therapy Market Challenges

1.3.4 Drug Addiction Therapy Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Drug Addiction Therapy Players Revenue Ranking (2023)

2.2 Global Drug Addiction Therapy Revenue by Company (2019-2024)

2.3 Key Companies Drug Addiction Therapy Manufacturing Base Distribution and Headquarters

2.4 Key Companies Drug Addiction Therapy Product Offered

2.5 Key Companies Time to Begin Mass Production of Drug Addiction Therapy

2.6 Drug Addiction Therapy Market Competitive Analysis

2.6.1 Drug Addiction Therapy Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Drug Addiction Therapy Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Addiction Therapy as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Tobacco

3.1.2 Nicotine

3.1.3 Vaping

3.2 Global Drug Addiction Therapy Sales Value by Type

3.2.1 Global Drug Addiction Therapy Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Drug Addiction Therapy Sales Value, by Type (2019-2030)

3.2.3 Global Drug Addiction Therapy Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Homecare

4.1.3 Drug Rehabilitation Center

4.2 Global Drug Addiction Therapy Sales Value by Application

4.2.1 Global Drug Addiction Therapy Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Drug Addiction Therapy Sales Value, by Application (2019-2030)

4.2.3 Global Drug Addiction Therapy Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Drug Addiction Therapy Sales Value by Region

5.1.1 Global Drug Addiction Therapy Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Drug Addiction Therapy Sales Value by Region (2019-2024)

5.1.3 Global Drug Addiction Therapy Sales Value by Region (2025-2030)

5.1.4 Global Drug Addiction Therapy Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Drug Addiction Therapy Sales Value, 2019-2030

5.2.2 North America Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Drug Addiction Therapy Sales Value, 2019-2030

5.3.2 Europe Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Drug Addiction Therapy Sales Value, 2019-2030

5.4.2 Asia Pacific Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Drug Addiction Therapy Sales Value, 2019-2030

5.5.2 South America Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Drug Addiction Therapy Sales Value, 2019-2030

5.6.2 Middle East & Africa Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Drug Addiction Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Drug Addiction Therapy Sales Value

6.3 United States

6.3.1 United States Drug Addiction Therapy Sales Value, 2019-2030

6.3.2 United States Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Drug Addiction Therapy Sales Value, 2019-2030

6.4.2 Europe Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Drug Addiction Therapy Sales Value, 2019-2030

6.5.2 China Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.5.3 China Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Drug Addiction Therapy Sales Value, 2019-2030

6.6.2 Japan Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Drug Addiction Therapy Sales Value, 2019-2030

6.7.2 South Korea Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Drug Addiction Therapy Sales Value, 2019-2030

6.8.2 Southeast Asia Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Drug Addiction Therapy Sales Value, 2019-2030

6.9.2 India Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

6.9.3 India Drug Addiction Therapy Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer,Inc.

7.1.1 Pfizer,Inc. Profile

7.1.2 Pfizer,Inc. Main Business

7.1.3 Pfizer,Inc. Drug Addiction Therapy Products, Services and Solutions

7.1.4 Pfizer,Inc. Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.1.5 Pfizer,Inc. Recent Developments

7.2 Indivior PLC

7.2.1 Indivior PLC Profile

7.2.2 Indivior PLC Main Business

7.2.3 Indivior PLC Drug Addiction Therapy Products, Services and Solutions

7.2.4 Indivior PLC Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.2.5 Indivior PLC Recent Developments

7.3 Novartis AG

7.3.1 Novartis AG Profile

7.3.2 Novartis AG Main Business

7.3.3 Novartis AG Drug Addiction Therapy Products, Services and Solutions

7.3.4 Novartis AG Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.3.5 Alkermes Recent Developments

7.4 Alkermes

7.4.1 Alkermes Profile

7.4.2 Alkermes Main Business

7.4.3 Alkermes Drug Addiction Therapy Products, Services and Solutions

7.4.4 Alkermes Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.4.5 Alkermes Recent Developments

7.5 Viatris,Inc.

7.5.1 Viatris,Inc. Profile

7.5.2 Viatris,Inc. Main Business

7.5.3 Viatris,Inc. Drug Addiction Therapy Products, Services and Solutions

7.5.4 Viatris,Inc. Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.5.5 Viatris,Inc. Recent Developments

7.6 Teva Pharmaceutical Industries,Ltd.

7.6.1 Teva Pharmaceutical Industries,Ltd. Profile

7.6.2 Teva Pharmaceutical Industries,Ltd. Main Business

7.6.3 Teva Pharmaceutical Industries,Ltd. Drug Addiction Therapy Products, Services and Solutions

7.6.4 Teva Pharmaceutical Industries,Ltd. Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.6.5 Teva Pharmaceutical Industries,Ltd. Recent Developments

7.7 Mallinckrodt Pharmaceutical

7.7.1 Mallinckrodt Pharmaceutical Profile

7.7.2 Mallinckrodt Pharmaceutical Main Business

7.7.3 Mallinckrodt Pharmaceutical Drug Addiction Therapy Products, Services and Solutions

7.7.4 Mallinckrodt Pharmaceutical Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.7.5 Mallinckrodt Pharmaceutical Recent Developments

7.8 Hikma Pharmaceuticals PLC

7.8.1 Hikma Pharmaceuticals PLC Profile

7.8.2 Hikma Pharmaceuticals PLC Main Business

7.8.3 Hikma Pharmaceuticals PLC Drug Addiction Therapy Products, Services and Solutions

7.8.4 Hikma Pharmaceuticals PLC Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.8.5 Hikma Pharmaceuticals PLC Recent Developments

7.9 Orexo AB

7.9.1 Orexo AB Profile

7.9.2 Orexo AB Main Business

7.9.3 Orexo AB Drug Addiction Therapy Products, Services and Solutions

7.9.4 Orexo AB Drug Addiction Therapy Revenue (US$ Million) & (2019-2024)

7.9.5 Orexo AB Recent Developments

8 Industry Chain Analysis

8.1 Drug Addiction Therapy Industrial Chain

8.2 Drug Addiction Therapy Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Drug Addiction Therapy Sales Model

8.5.2 Sales Channel

8.5.3 Drug Addiction Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical Industries Ltd

Hikma Pharmaceuticals PLC

Orexo

Mallinckrodt Pharmaceutical

List of Tables

Table 1. Drug Addiction Therapy Market Trends

Table 2. Drug Addiction Therapy Market Drivers & Opportunity

Table 3. Drug Addiction Therapy Market Challenges

Table 4. Drug Addiction Therapy Market Restraints

Table 5. Global Drug Addiction Therapy Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Drug Addiction Therapy Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Drug Addiction Therapy Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Drug Addiction Therapy Product Type

Table 9. Key Companies Time to Begin Mass Production of Drug Addiction Therapy

Table 10. Global Drug Addiction Therapy Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Addiction Therapy as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Drug Addiction Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Drug Addiction Therapy Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Drug Addiction Therapy Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Drug Addiction Therapy Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Drug Addiction Therapy Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Drug Addiction Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Drug Addiction Therapy Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Drug Addiction Therapy Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Drug Addiction Therapy Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Drug Addiction Therapy Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Drug Addiction Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Drug Addiction Therapy Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Drug Addiction Therapy Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Drug Addiction Therapy Sales Value by Region (2019-2024) & (%)

Table 27. Global Drug Addiction Therapy Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Drug Addiction Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Drug Addiction Therapy Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Drug Addiction Therapy Sales Value, (2025-2030) & (US$ Million)

Table 31. Pfizer,Inc. Basic Information List

Table 32. Pfizer,Inc. Description and Business Overview

Table 33. Pfizer,Inc. Drug Addiction Therapy Products, Services and Solutions

Table 34. Revenue (US$ Million) in Drug Addiction Therapy Business of Pfizer,Inc. (2019-2024)

Table 35. Pfizer,Inc. Recent Developments

Table 36. Indivior PLC Basic Information List

Table 37. Indivior PLC Description and Business Overview

Table 38. Indivior PLC Drug Addiction Therapy Products, Services and Solutions

Table 39. Revenue (US$ Million) in Drug Addiction Therapy Business of Indivior PLC (2019-2024)

Table 40. Indivior PLC Recent Developments

Table 41. Novartis AG Basic Information List

Table 42. Novartis AG Description and Business Overview

Table 43. Novartis AG Drug Addiction Therapy Products, Services and Solutions

Table 44. Revenue (US$ Million) in Drug Addiction Therapy Business of Novartis AG (2019-2024)

Table 45. Novartis AG Recent Developments

Table 46. Alkermes Basic Information List

Table 47. Alkermes Description and Business Overview

Table 48. Alkermes Drug Addiction Therapy Products, Services and Solutions

Table 49. Revenue (US$ Million) in Drug Addiction Therapy Business of Alkermes (2019-2024)

Table 50. Alkermes Recent Developments

Table 51. Viatris,Inc. Basic Information List

Table 52. Viatris,Inc. Description and Business Overview

Table 53. Viatris,Inc. Drug Addiction Therapy Products, Services and Solutions

Table 54. Revenue (US$ Million) in Drug Addiction Therapy Business of Viatris,Inc. (2019-2024)

Table 55. Viatris,Inc. Recent Developments

Table 56. Teva Pharmaceutical Industries,Ltd. Basic Information List

Table 57. Teva Pharmaceutical Industries,Ltd. Description and Business Overview

Table 58. Teva Pharmaceutical Industries,Ltd. Drug Addiction Therapy Products, Services and Solutions

Table 59. Revenue (US$ Million) in Drug Addiction Therapy Business of Teva Pharmaceutical Industries,Ltd. (2019-2024)

Table 60. Teva Pharmaceutical Industries,Ltd. Recent Developments

Table 61. Mallinckrodt Pharmaceutical Basic Information List

Table 62. Mallinckrodt Pharmaceutical Description and Business Overview

Table 63. Mallinckrodt Pharmaceutical Drug Addiction Therapy Products, Services and Solutions

Table 64. Revenue (US$ Million) in Drug Addiction Therapy Business of Mallinckrodt Pharmaceutical (2019-2024)

Table 65. Mallinckrodt Pharmaceutical Recent Developments

Table 66. Hikma Pharmaceuticals PLC Basic Information List

Table 67. Hikma Pharmaceuticals PLC Description and Business Overview

Table 68. Hikma Pharmaceuticals PLC Drug Addiction Therapy Products, Services and Solutions

Table 69. Revenue (US$ Million) in Drug Addiction Therapy Business of Hikma Pharmaceuticals PLC (2019-2024)

Table 70. Hikma Pharmaceuticals PLC Recent Developments

Table 71. Orexo AB Basic Information List

Table 72. Orexo AB Description and Business Overview

Table 73. Orexo AB Drug Addiction Therapy Products, Services and Solutions

Table 74. Revenue (US$ Million) in Drug Addiction Therapy Business of Orexo AB (2019-2024)

Table 75. Orexo AB Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Drug Addiction Therapy Downstream Customers

Table 79. Drug Addiction Therapy Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Drug Addiction Therapy Product Picture

Figure 2. Global Drug Addiction Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 4. Drug Addiction Therapy Report Years Considered

Figure 5. Global Drug Addiction Therapy Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Addiction Therapy Revenue in 2023

Figure 7. Drug Addiction Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Tobacco Picture

Figure 9. Nicotine Picture

Figure 10. Vaping Picture

Figure 11. Global Drug Addiction Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Drug Addiction Therapy Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospitals

Figure 14. Product Picture of Homecare

Figure 15. Product Picture of Drug Rehabilitation Center

Figure 16. Global Drug Addiction Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Drug Addiction Therapy Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Drug Addiction Therapy Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Drug Addiction Therapy Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Drug Addiction Therapy Sales Value (%), (2019-2030)

Figure 29. United States Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 35. China Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 37. China Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 47. India Drug Addiction Therapy Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Drug Addiction Therapy Sales Value by Type (%), 2023 VS 2030

Figure 49. India Drug Addiction Therapy Sales Value by Application (%), 2023 VS 2030

Figure 50. Drug Addiction Therapy Industrial Chain

Figure 51. Drug Addiction Therapy Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions